Post by account_disabled on Mar 5, 2024 19:41:34 GMT -8
Rival brands are a constant in the business world and knowing about them is nothing new: McDonald's vs Burger King, Adidas vs Puma, Nikon vs Canon and the list goes on. What is a surprise is the way in which many of them have managed to overcome this rivalry in favor of society.
A peculiar story is the one that McDonald's starred in a few years ago in Argentina through its charitable foundation. During his annual “McHappy Day” giving day, he supported the fight against childhood cancer by donating all profits from Big Mac sales in that time period.
This Social Responsibility (SR) initiative Ecuador Mobile Number List would have gone unnoticed had it not been for Burger King joining in by deciding not to sell Whoppers and referring their customers to McDonald's to help their competition raise as much money as possible. And to top it off... there was no greater symbol of this support than seeing Burger King itself entering McDonald's.
alliance between rival brands
Currently, a truly strong situation unites us and the pandemic is bringing out the best in many companies to create alliances between rival brands. The most recent example is given by Merck and J&J. Both will work together to manufacture vaccines against COVID-19 .
Merck and Johnson & Johnson
Merck Group is a German multinational manufacturer of pharmaceutical, chemical, and biotechnology products. According to the company, it works to generate quality of life for its patients, consumers and society.
alliance between rival brands
On the other hand, Johnson & Johnson is an American multinational company, manufacturer of medical devices, pharmaceuticals, personal care products, perfumes and more. The company believes that its first responsibility is to the doctors, nurses and patients, to the mothers and fathers and everyone else who uses its products and services.
alliance between rival brands
The commitment of both companies is very clear: the well-being of people.
For this reason, they have taken it upon themselves to create a significant alliance in one of the most critical moments for humanity.
The pandemic creates alliances between rival brands
Following reporting from The Washington Post, Joe Biden is about to announce that Merck will help manufacture Johnson & Johnson's single-shot coronavirus vaccine. This alliance between rival brands is unusual, however, it could greatly help increase the supply of the newly authorized vaccine, according to senior administration officials.
Those officials, whose identities are known, say they began scouring the country for additional manufacturing capacity after they realized in the early days of the administration that Johnson & Johnson had fallen behind in vaccine production. .
alliance between rival brands
That fact caused them to seek to negotiate a deal with Merck, one of the world's largest vaccine manufacturers that had been unable to develop its own COVID-19 vaccine.
Historical Association
Under the agreement, Merck will dedicate two facilities in the United States to Johnson & Johnson shots. One will provide “fill and finish” services, the last stage of the production process during which the vaccine substance is placed in vials and packaged for distribution. The other will make the vaccine and has the potential to vastly increase supply, perhaps even doubling what Johnson & Johnson could do on its own.
"It's a historic partnership," one of the officials said, adding that the companies "recognize that this is a wartime effort." He praised their sense of “corporate citizenship.”
Officials declined to provide details on how Merck's involvement will affect the projected supply of the Johnson & Johnson vaccine and the timeline for distributing it. It could easily take two months to get the “fill-finish” plant ready and a few more months to equip the other facility to make the vaccine, according to a person familiar with the process who spoke on condition of anonymity because he was not authorized to discuss the matter. .
Johnson & Johnson is currently conducting a trial of a two-shot vaccine regimen, with doses given two months apart, but results are not expected until at least May. And although both companies are taking very good care of the information that is made public, Merck commented that it "remains firm in its commitment to contributing to the global response to the pandemic.